retatrutide ly3437943 glp-1 gip glucagon triple agonist phase 2 results LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: Reta GLP-3R (Retatrutide) 10mg |
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21


























